EQ

Equillium Inc
1.24
0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Equillium Inc EQ NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.24 04:22:12
Open Price Low Price High Price Close Price Prev Close
1.24
more quote information »

Recent News

Date Time Source Heading
2/07/202318:53EDGARStatement of Changes in Beneficial Ownership (4)
2/07/202318:46EDGARStatement of Changes in Beneficial Ownership (4)
2/07/202318:43EDGARStatement of Changes in Beneficial Ownership (4)
2/07/202318:37EDGARStatement of Changes in Beneficial Ownership (4)
2/07/202318:35EDGARStatement of Changes in Beneficial Ownership (4)
2/07/202308:00BWEquillium to Present at the SVB Securities Annual Global..
1/13/202308:00BWEquillium Announces Abstract Accepted for Oral Presentation..
1/06/202317:14EDGARSecurities Registration: Employee Benefit Plan (s-8)
1/06/202317:12EDGARSecurities Registration Statement (simplified Form) (s-3)
1/04/202318:54EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202318:51EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202318:49EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202318:46EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202318:44EDGARStatement of Changes in Beneficial Ownership (4)
12/23/202216:12EDGARCurrent Report Filing (8-k)
12/23/202216:01BWEquillium and Metacrine Mutually Agree to Terminate..
12/16/202208:00BWEquillium’s Partner Biocon Initiates Phase 2 Study of..
12/06/202208:01DJNEquillium Shares Rally Premarket on Itolizumab Pact With Ono
12/06/202207:04EDGARFiling of Certain Prospectuses and Communications in..
12/06/202207:01EDGARCurrent Report Filing (8-k)
12/06/202207:00BWEquillium and Ono Pharmaceutical Announce Exclusive Option..
11/14/202217:51EDGARQuarterly Report (10-q)
11/14/202216:38EDGARFiling of Certain Prospectuses and Communications in..
11/14/202216:19EDGARCurrent Report Filing (8-k)
11/14/202216:01BWEquillium Reports Third Quarter 2022 Financial Results and..
11/14/202208:00BWEquillium Announces Data Suggesting Soluble ALCAM as a..
11/14/202206:07EDGARNotice of Effectiveness (effect)
11/10/202216:16EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
11/10/202208:00BWEquillium Announces Initiation of Phase 2 study of EQ101 A..
11/09/202216:35EDGARRegistration Statement for Securities to Be Issued in..
11/08/202208:00BWEquillium to Present at Two Upcoming Investor Conferences
11/03/202208:00BWEquillium Announces Presentation at the 6th Annual..
11/02/202208:00BWEquillium Announces Initiation of Phase 1 study of EQ102, A..
10/26/202208:00BWEquillium Announces Presentation of Data Demonstrating..
9/27/202209:29EDGARCurrent Report Filing (8-k)
9/27/202207:00BWEquillium Announces Positive Interim Results from the..
9/26/202217:27EDGARCurrent Report Filing (8-k)
9/15/202208:00BWEquillium Announces Abstract Accepted for Presentation at..
9/06/202216:30EDGARCurrent Report Filing (8-k)
9/06/202216:00BWEquillium to Acquire Metacrine in All-Stock Transaction
8/31/202208:00BWEquillium to Present at Two Upcoming Investor Conferences
8/30/202217:58EDGARStatement of Changes in Beneficial Ownership (4)
8/15/202216:55EDGARQuarterly Report (10-q)
8/15/202216:26EDGARCurrent Report Filing (8-k)
8/15/202216:01BWEquillium Reports Second Quarter 2022 Financial Results and..
7/28/202208:00BWEquillium Announces Presentation at the 3rd Annual..
5/25/202219:55EDGARStatement of Changes in Beneficial Ownership (4)
5/25/202219:53EDGARStatement of Changes in Beneficial Ownership (4)
5/25/202219:51EDGARStatement of Changes in Beneficial Ownership (4)
5/25/202219:47EDGARStatement of Changes in Beneficial Ownership (4)